Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase I and II Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of Adipose Tissue in Age-dependent Sensitivity to Critical Illness
Genetic Analysis of LIS1 Function in the Mouse
Chromosome Analysis of Single Cells
Selective Therapy of Tumors That Overexpress C Myc
Lung Disease in Scleroderma
Recently added grants:
Redefining the Role of APOE RNA Transcripts in Alzheimer's Disease
Exosome-mediated mechanisms of metastatic disease in non-small cell lung cancer
Identification of the Molecular Mechanisms Linking Alzheimer's Disease, PERK, and Mild Repetitive Head Injury
Developing Neuronal KCNQ Channel Modulators for Mood Disorders
ResCU II: Improving In-hospital Cardiac Arrest Care and Discovering Keys to Super-Survivorship
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35160-8-0-1
Application #
7579646
Study Section
Project Start
2003-09-30
Project End
2009-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/ University of California Irvine
$750,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Cancer Chemopreventive Agents
Meyskens, Frank Louis /
$1,577,000
NIH 2007
N01 CA
Phase I and II Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant